Search hospitals > California > San Rafael
Kaiser Permanente-San Rafael
Claim this profileSan Rafael, California 94903
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Colorectal Cancer
Conducts research for Adenocarcinoma
150 reported clinical trials
4 medical researchers
Summary
Kaiser Permanente-San Rafael is a medical facility located in San Rafael, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Adenocarcinoma and other specialties. Kaiser Permanente-San Rafael is involved with conducting 150 clinical trials across 306 conditions. There are 4 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Ramey D. Littell.Area of expertise
1Cancer
Global LeaderStage II
Stage III
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
98 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo7 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
21 reported clinical trials
51 drugs studied
Ramey D. LittellKaiser Permanente-Roseville4 years of reported clinical research
Studies Ovarian Cancer
Studies Adenocarcinoma
5 reported clinical trials
13 drugs studied
Clinical Trials running at Kaiser Permanente-San Rafael
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Meningioma
ALK Gene Rearrangement
Skin Cancer
Cutaneous Melanoma
Brain Metastasis
Tumors
Cardiotoxicity
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente-San Rafael?
Kaiser Permanente-San Rafael is a medical facility located in San Rafael, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Adenocarcinoma and other specialties. Kaiser Permanente-San Rafael is involved with conducting 150 clinical trials across 306 conditions. There are 4 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Ramey D. Littell.